Skip to main content
Chest
Clara cell protein CC16. A new lung epithelial biomarker for acute lung injury.
Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure.
Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.
Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response.
Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy.
Reasons for nonenrollment in a clinical trial of acute lung injury.
Illnesses at high altitude.
Aerosolized beta-adrenergic agonist therapy reduces pulmonary edema following lung surgery.
Utility of CT for predicting pulmonary hypertension in patients with parenchymal lung disease: similar results, different conclusion?
Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study.
